Trump’s MFN price controls aren’t the answer to America’s high patented drug pricing, but trade deals may be.
Right Diagnosis, Wrong Cure
Comment
Show comments
Hide Comments
Trump’s MFN price controls aren’t the answer to America’s high patented drug pricing, but trade deals may be.
